Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis.
<h4>Objective</h4>Postpartum depression (PPD) is a major mental health issue affecting 10%-15% of women globally. This meta-analysis synthesized updated evidence on sub-anesthetic ketamine/esketamine's efficacy in preventing PPD.<h4>Methods</h4>Randomized controlled tria...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0310751 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846161739709677568 |
|---|---|
| author | Kuo-Chuan Hung Chia-Li Kao Yi-Chen Lai Jen-Yin Chen Chien-Hung Lin Ching-Chung Ko Chien-Ming Lin I-Wen Chen |
| author_facet | Kuo-Chuan Hung Chia-Li Kao Yi-Chen Lai Jen-Yin Chen Chien-Hung Lin Ching-Chung Ko Chien-Ming Lin I-Wen Chen |
| author_sort | Kuo-Chuan Hung |
| collection | DOAJ |
| description | <h4>Objective</h4>Postpartum depression (PPD) is a major mental health issue affecting 10%-15% of women globally. This meta-analysis synthesized updated evidence on sub-anesthetic ketamine/esketamine's efficacy in preventing PPD.<h4>Methods</h4>Randomized controlled trials (RCTs) comparing ketamine/esketamine to a placebo for PPD prevention were searched without language restriction. Primary outcomes were PPD risk at 1- and 4-6-week postpartum. Secondary outcomes included the difference in depression scores and risk of adverse events. Trial sequential analysis (TSA) was conducted to validate the reliability.<h4>Results</h4>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3-0.57) and 4-6-week (RR, 0.47; 95%CI, 0.35-0.63) follow-ups. Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], -0.94; 95%CI, -1.26 to -0.62) and 4-6-week (SMD, -0.89; 95%CI, -1.25 to -0.53) follow-ups. Despite potential publication bias, TSA confirmed the evidence's reliability. Subgroup analysis showed that ketamine/esketamine's preventive effect on 1-week PPD was consistent, regardless of administration timing, type of agents, or total dosage (<0.5 vs. ≥0.5 mg/kg). For the 4-6-week period, PPD risk was favorably reduced only with postoperative administration or the use of esketamine, with the total dosage having no observed influence. Participants on ketamine/esketamine experienced more frequency of hallucinations (RR, 4.77; 95%CI, 1.39-16.44) and dizziness (RR, 1.36; 95%CI, 1.02-1.81).<h4>Conclusion</h4>Our findings advocate for the postoperative administration of low-dose ketamine/esketamine to avert PPD, which needed additional research for confirmation. |
| format | Article |
| id | doaj-art-43aea86cb23e44e8a88d6e1d2ea0ff31 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-43aea86cb23e44e8a88d6e1d2ea0ff312024-11-21T05:31:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011911e031075110.1371/journal.pone.0310751Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis.Kuo-Chuan HungChia-Li KaoYi-Chen LaiJen-Yin ChenChien-Hung LinChing-Chung KoChien-Ming LinI-Wen Chen<h4>Objective</h4>Postpartum depression (PPD) is a major mental health issue affecting 10%-15% of women globally. This meta-analysis synthesized updated evidence on sub-anesthetic ketamine/esketamine's efficacy in preventing PPD.<h4>Methods</h4>Randomized controlled trials (RCTs) comparing ketamine/esketamine to a placebo for PPD prevention were searched without language restriction. Primary outcomes were PPD risk at 1- and 4-6-week postpartum. Secondary outcomes included the difference in depression scores and risk of adverse events. Trial sequential analysis (TSA) was conducted to validate the reliability.<h4>Results</h4>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3-0.57) and 4-6-week (RR, 0.47; 95%CI, 0.35-0.63) follow-ups. Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], -0.94; 95%CI, -1.26 to -0.62) and 4-6-week (SMD, -0.89; 95%CI, -1.25 to -0.53) follow-ups. Despite potential publication bias, TSA confirmed the evidence's reliability. Subgroup analysis showed that ketamine/esketamine's preventive effect on 1-week PPD was consistent, regardless of administration timing, type of agents, or total dosage (<0.5 vs. ≥0.5 mg/kg). For the 4-6-week period, PPD risk was favorably reduced only with postoperative administration or the use of esketamine, with the total dosage having no observed influence. Participants on ketamine/esketamine experienced more frequency of hallucinations (RR, 4.77; 95%CI, 1.39-16.44) and dizziness (RR, 1.36; 95%CI, 1.02-1.81).<h4>Conclusion</h4>Our findings advocate for the postoperative administration of low-dose ketamine/esketamine to avert PPD, which needed additional research for confirmation.https://doi.org/10.1371/journal.pone.0310751 |
| spellingShingle | Kuo-Chuan Hung Chia-Li Kao Yi-Chen Lai Jen-Yin Chen Chien-Hung Lin Ching-Chung Ko Chien-Ming Lin I-Wen Chen Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis. PLoS ONE |
| title | Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis. |
| title_full | Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis. |
| title_fullStr | Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis. |
| title_full_unstemmed | Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis. |
| title_short | Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis. |
| title_sort | perioperative administration of sub anesthetic ketamine esketamine for preventing postpartum depression symptoms a trial sequential meta analysis |
| url | https://doi.org/10.1371/journal.pone.0310751 |
| work_keys_str_mv | AT kuochuanhung perioperativeadministrationofsubanestheticketamineesketamineforpreventingpostpartumdepressionsymptomsatrialsequentialmetaanalysis AT chialikao perioperativeadministrationofsubanestheticketamineesketamineforpreventingpostpartumdepressionsymptomsatrialsequentialmetaanalysis AT yichenlai perioperativeadministrationofsubanestheticketamineesketamineforpreventingpostpartumdepressionsymptomsatrialsequentialmetaanalysis AT jenyinchen perioperativeadministrationofsubanestheticketamineesketamineforpreventingpostpartumdepressionsymptomsatrialsequentialmetaanalysis AT chienhunglin perioperativeadministrationofsubanestheticketamineesketamineforpreventingpostpartumdepressionsymptomsatrialsequentialmetaanalysis AT chingchungko perioperativeadministrationofsubanestheticketamineesketamineforpreventingpostpartumdepressionsymptomsatrialsequentialmetaanalysis AT chienminglin perioperativeadministrationofsubanestheticketamineesketamineforpreventingpostpartumdepressionsymptomsatrialsequentialmetaanalysis AT iwenchen perioperativeadministrationofsubanestheticketamineesketamineforpreventingpostpartumdepressionsymptomsatrialsequentialmetaanalysis |